MétaCan
Menu
Back to cohort
Record W3157567544 · doi:10.1002/ana.26094

Genomewide Association Studies of <scp> <i>LRRK2</i> </scp> Modifiers of Parkinson's Disease

2021· article· en· W3157567544 on OpenAlexafffund
Dongbing Lai, Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay, Gary W. Beecham, Daniela Berg, Susan Bressman, Alexis Brice, Lorraine N. Clark, Mark Cookson, Sayantan Das, Vivianna M. Van Deerlin, Jordan Follett, Matthew J. Farrer, Joanne Trinh, Thomas Gasser, Stefano Goldwurm, Emil K. Gustavsson, Christine Klein, Anthony E. Lang, J. William Langston, Jeanne C. Latourelle, Timothy Lynch, Karen Marder, Connie Marras, Eden R. Martin, Cory Y. McLean, Helen Mejia‐Santana, Eric Molho, Richard H. Myers, Karen Nuytemans, Laurie J. Ozelius, Haydeh Payami, Deborah Raymond, Ekaterina Rogaeva, Michael P. Rogers, Owen A. Ross, Ali Samii, Rachel Saunders‐Pullman, Birgitt Schüle, Claudia Schulte, William K. Scott, Caroline M. Tanner, Eduardo Tolosa, James E. Tomkins, Dolores Vilas, John Q. Trojanowski, Ryan J. Uitti, Jeffery M. Vance, Naomi P. Visanji, Zbigniew K. Wszołek, Cyrus P. Zabetian, Anat Mirelman, Nir Giladi, Avi Orr Urtreger, P. F. Cannon, Brian Fiske, Tatiana Foroud

Bibliographic record

VenueAnnals of Neurology · 2021
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsOccupational Cancer Research CentreUniversity of TorontoToronto Western HospitalOkanagan University CollegeUniversity of British Columbia, Okanagan CampusUniversity of British Columbia
FundersNational Institute of Neurological Disorders and StrokeNational Heart, Lung, and Blood InstituteNational Institute on AgingCanadian Institutes of Health ResearchNational Center for Advancing Translational SciencesMorsani College of MedicineSchool of Medicine, Stanford UniversityNational Institutes of HealthSorbonne UniversitéSt. Olavs Hospital Universitetssykehuset i TrondheimUniversität zu KölnUniversitat de BarcelonaCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasCentre National de la Recherche ScientifiqueTel Aviv UniversityUniversity of WashingtonJohns Hopkins UniversityEberhard Karls Universität TübingenInstitut National de la Santé et de la Recherche MédicaleDeutsche ForschungsgemeinschaftGoogleUniversity College DublinUniversity of ReadingOracleConsortium canadien en neurodégénérescence associée au vieillissementAlbertson Parkinson's Research FoundationAgence Nationale de la RechercheSol Goldman Charitable TrustClinical and Translational Science Institute, University of FloridaParkinson's FoundationUniversity of PennsylvaniaLittle Family FoundationMichael J. Fox Foundation for Parkinson's ResearchUniversity of MiamiDeutsches Zentrum für Neurodegenerative ErkrankungenMcKnight FoundationSagol School of Neuroscience, Tel Aviv UniversityUniversity of California, San FranciscoBrookdale FoundationVagelos College of Physicians and Surgeons, Columbia UniversityLeonard M. Miller School of MedicineUniversity of TorontoU.S. Department of Veterans AffairsUniversity of South FloridaU.S. Department of Defense
KeywordsPenetranceLRRK2GeneticsDiseaseParkinson's diseaseAlleleMutationBiologyOncologyMedicineInternal medicineGenePhenotype

Abstract

fetched live from OpenAlex

OBJECTIVE: The aim of this study was to search for genes/variants that modify the effect of LRRK2 mutations in terms of penetrance and age-at-onset of Parkinson's disease. METHODS: We performed the first genomewide association study of penetrance and age-at-onset of Parkinson's disease in LRRK2 mutation carriers (776 cases and 1,103 non-cases at their last evaluation). Cox proportional hazard models and linear mixed models were used to identify modifiers of penetrance and age-at-onset of LRRK2 mutations, respectively. We also investigated whether a polygenic risk score derived from a published genomewide association study of Parkinson's disease was able to explain variability in penetrance and age-at-onset in LRRK2 mutation carriers. RESULTS: A variant located in the intronic region of CORO1C on chromosome 12 (rs77395454; p value = 2.5E-08, beta = 1.27, SE = 0.23, risk allele: C) met genomewide significance for the penetrance model. Co-immunoprecipitation analyses of LRRK2 and CORO1C supported an interaction between these 2 proteins. A region on chromosome 3, within a previously reported linkage peak for Parkinson's disease susceptibility, showed suggestive associations in both models (penetrance top variant: p value = 1.1E-07; age-at-onset top variant: p value = 9.3E-07). A polygenic risk score derived from publicly available Parkinson's disease summary statistics was a significant predictor of penetrance, but not of age-at-onset. INTERPRETATION: This study suggests that variants within or near CORO1C may modify the penetrance of LRRK2 mutations. In addition, common Parkinson's disease associated variants collectively increase the penetrance of LRRK2 mutations. ANN NEUROL 2021;90:82-94.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.332
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations49
Published2021
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of NeurologySame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207